Dr. Marcom is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4101 N Roxboro St
Durham, NC 27704Phone+1 919-684-8111
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 1992 - 1995- Duke University HospitalResidency, Internal Medicine, 1989 - 1992
Baylor College of MedicineClass of 1989
Certifications & Licensure
NC State Medical License 1991 - 2025- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2008-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- America's Top Doctors for Cancer Castle Connolly, 2007-2013
- Join now to see all
Clinical Trials
- A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel Start of enrollment: 2003 Oct 01
- Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC Start of enrollment: 2000 Jan 01
- Trial to Evaluate Genomic Expression Profiles to Direct Preoperative Chemotherapy in Early Stage Breast Cancer Start of enrollment: 2008 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 22 citationsEarly Stage HER2-Positive Breast Cancers Not Achieving a pCR From Neoadjuvant Trastuzumab- or Pertuzumab-Based Regimens Have an Immunosuppressive Phenotype.Jeremy Force, Lynn Howie, Sara Abbott, Rex C. Bentley, P. Kelly Marcom
Clinical Breast Cancer. 2018-10-01 - 1270 citationsClinical practice guidelines in oncologyWilliam J. Gradishar, Benjamin O. Anderson, Ron Balassanian, Sarah L. Blair, Harold J. Burstein
Journal of the National Comprehensive Cancer Network. 2018-03-01 - 234 citationsGenetic/familial high-risk assessment: Breast and ovarian, version 2.2015 Featured updates to the NCCN guidelinesMary B. Daly, Robert Pilarski, Jennifer E. Axilbund, Michael Berry, Saundra S. Buys
Journal of the National Comprehensive Cancer Network. 2016-02-01
Press Mentions
Veracyte Announces Two Pre-Eminent Physician Appointments, Further Strengthening Medical TeamJuly 1st, 2021
Novel Combinations Key to Advancing HR+ Breast Cancer CareDecember 27th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
